FDA Approves Bulevirtide for Hepatitis Delta Virus

[ad_1]

Bulevirtide (Hepcludex; Gilead Sciences, Inc.) is the first FDA-approved treatment for chronic hepatitis delta virus infection.
Medscape Medical News

[ad_2]

Source link : https://www.medscape.com/viewarticle/fda-approves-bulevirtide-hepatitis-delta-virus-2026a1000h3x?src=rss

Author :

Publish date : 2026-05-26 06:16:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version